A start-up whose technology should make it faster to develop new drugs
Christchurch, New ZealandHealthtech
2 sources · checked 4 times, last 1h ago
Dealroom is quoted at US$8.41 million, but the specific Herald report states US$7.3 million ($12.8m), which is used here.
Investors read as leads [M Ventures], participants [Bridgewest Ventures NZ, Icehouse Ventures, New Zealand Growth Capital Partners] (b2bnews.co.nz): investor split: Merck's M Ventures led, not Singapore's M Venture Partners; the old one-letter key had joined them
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $7.3M | 2026-10-11 | M Ventures | No recent discussion |
2 sources · checked 4 times, last 1h ago [ VERIFIED · CORRECTED ] read against 2 sources
Dealroom is quoted at US$8.41 million, but the specific Herald report states US$7.3 million ($12.8m), which is used here. Investors read as leads [M Ventures], participants [Bridgewest Ventures NZ, Icehouse Ventures, New Zealand Growth Capital Partners] (b2bnews.co.nz): investor split: Merck's M Ventures led, not Singapore's M Venture Partners; the old one-letter key had joined them [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: b2bnews.co.nz, nzherald.co.nz·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 2 sources | ||||